Good point. Perhaps someone in the US will buy the company out....

Good point. Perhaps someone in the US will buy the company out. Not enough market cap to list there as yet. No one (or very few out here) get the value. This is happening in a some biotech's but the US tax cuts are making acquisitions more attractive.
If someone bid $1.50 for this, it would be cheap given the size of the market in the US alone. This is one of those stocks that is a sleeper. The light will turn on for some fund on more contracts and it will take off imo. I have 100k in the bottom draw for the eventual wake up call. Most Biotech's are years away from revenues, but CG1 has now cracked that nut and due to move into profitability. Some of the current contracts are with power companies who own /control 10-20 power stations, so one can see the upside potential here. I have always wondered where and why a company was not formed to address this problem, and here it is. It will require patience, but decent stocks have their days. dyor.